- Gastroenterology Advisor

Ulcerative Colitis

Ulcerative colitis

Latest News


Vedolizumab: Safe Long-Term for UC and CD

Alimentary Pharmacology and Therapeutics reports on the final results from the GEMINI long-term safety study on vedolizumab, a gut-selective α4 β7 integrin antibody approved for moderately to severely active ulcerative colitis and Crohn disease.